OXFORD VACCINE RAISES HOPES

The AstraZeneca-Oxford coronavirus vaccine, one of the frontrunners in the global vaccine race, has produced an immune response in both young and old. The announcement has raised hopes as the Covid-19 pandemic continues to damage global economies.

The coronavirus vaccine has also triggered lower adverse responses among the elderly, British drug maker AstraZeneca has said.

“It is encouraging to see immunogenicity responses were similar between older and younger adults and that reactogenicity was lower in older adults, where the Covid-19 disease severity is higher,” an AstraZeneca spokesman said.